But what does science say?

A group of researchers attempted to answer some of the most important questions about this plant in an article published May 16, 2019 in the International Journal of Drug Policy. In short, they have seen conflicting results. According to unofficial reports, kratom is effective in reducing opioid dependence, but “its effects have not been studied in controlled clinical trials in accordance with the requirements of regulatory authorities (eg FDA) to draw conclusions about the safety and efficacy of the drug for the treatment of [opioid use disorders ] or other indications ".

Despite the lack of large-scale studies, scientists cite several small scientific papers that suggest kratom as an effective treatment for opioid use disorders. For example, a small study in 2009 among Malaysians found that regular consumption of kratom helped reduce withdrawal symptoms from other drugs.

Does Kratom help with pain?

As the authors of the study note, several factors forced patients suffering from chronic pain to seek alternatives to traditional methods. One such factor is the US Centers for Disease Control and Prevention (CDC) opioid prescribing guidelines that urge physicians to limit opioid prescribing for the long term. This approach, experts recognized, negatively affected the well-being of patients who were denied access to opioid prescriptions.

Inverse informal reports that some patients who found unacceptable side effects of conventional opioids also switched to kratom. In a new study published in the International Journal of Drug Policy, experts come to a controversial conclusion about the pain relieving properties of kratom The substance has not been approved for this use in accordance with accepted medical procedures.

High-quality Bulk Kratom Pills in USA

Indications for use

Alcohol, tobacco and drug addiction - natural and mild substitution therapy. Not addictive. 2. Severe chronic pain. 3. Increased level of anxiety, psychological trauma, stress, depression. 4. Consequences of physical exertion, hard work. 5. Metabolic disorders, slow metabolism. 6. Elevated blood sugar. 7. Kratom leaf raises energy tone in case of loss of strength and weakness. 8. Weakened immunity. 9. Sexual disorders, sexual weakness.

Kratom legality

Currently in the vast majority of the surrounding world, Kratom can be freely purchased, but this can change dramatically at any time. The recent rise in popularity of Kratom has unexpectedly met with serious antagonism from various often government agencies, and several local authorities have ordered its sale and maximum use. This immediately sparked the interest of biomedical researchers around the outside world. Dr. Boyer, in particular a medical toxicologist in the Department of Toxicology, became seriously interested in scientific research after it was revealed that more than 40 dispossessed millions of real Americans obey unquestioningly from Kratom, which immediately caused a surge of desire for Kratom powder. While the free sale of kratom is legal in the vast majority of democracies, it isn't permitted in any way in southern Australia, Burma, Denmark, Germany, Israel, Lithuania, Malaysia, Myanmar, Poland, Romania, Russia, South Korea, and Thailand. So far as the United States is concerned, it is legal in most states except:

  • Alabama
  • – Illegal, legislature can be found here.
  • Arkansas
  • – Illegal, legislature can be found here.
  • Indiana
  • – Illegal, legislature can be found here.
  • Vermont
  • – Illegal, legislature can be found here.
  • Wisconsin
  • – Illegal, legislature can be found here.
  • Rhode Island
  • – Illegal. Counties that prohibit sale of Kratom:
  • Jerseyville
  • – IL
  • San Diego
  • – CA
  • Sarasota County
  • – FL

  • Kratom May Cause Liver Damage: Study. Drugs.com. Accessed February 26, 2020 at https://www.drugs.com/news/kratom-may-cause-liver-damage-study-86356.html
  • HHS recommended that the DEA make kratom a Schedule I drug, like LSD or heroin. STATNews. Accessed February 26, 2020 at https://www.statnews.com/2018/11/09/hhs-recommended-dea-ban-kratom-documents-show/
  • Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse. U.S. Food and Administration (FDA). Feb. 6, 2018. Accessed February 26, 2020 at https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-agencys-scientific-evidence-presence-opioid-compounds
  • Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom. U.S. Food and Administration (FDA). Nov. 14, 2017. Accessed February 26, 2020 at https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-fda-advisory-about-deadly-risks-associated-kratom
  • Herbal Drug Kratom Contains Opioids, FDA Says. Drugs.com. Feb. 7, 2018. Accessed February 26, 2020 at https://www.drugs.com/news/herbal-kratom-contains-opioids-fda-says-68620.html
  • FDA News release. January 2016. US Marshals seize dietary supplements containing Kratom. Accessed October 6, 2016.
  • Gianutsos G. The DEA Changes Its Mind on Kratom. US Pharm. 2017;41(3):7-9. Accessed Feb. 8, 2018 at https://www.uspharmacist.com/article/the-dea-changes-its-mind-on-kratom
  • Rosenbaum et al. Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines. J Med Toxicol. 2012; 8(1):15–32.
  • Kronstrad, et al. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol. 2011; 35:242-7.
  • DEA. Micrograms Bulletin. March 2006. Accessed October 6, 2016.
  • Kapp FG, Maurer HH, Auwärter V, Winkelmann M, Hermanns-Clausen M. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol 2011; 7: 227-31.
  • DEA. Kratom. Drug Facts Sheet. p. 29. Accessed February 26, 2020.
  • Schedules of Controlled Substances: Temporary Placement of Mitragynine and 7-Hydroxymitragynine Into Schedule I. Federal Register. Proposed Rule by the DEA, 8/31/2016. Accessed February 26, 2020.
  • Drugs of Abuse. A DEA Resource Guide. 2015 Edition. Drugs of Concern. Kratom. p 84. Accessed October 6, 2016.
  • Kratom seized in California by US Marshals Service. FDA news Release. August 4, 2016. Accessed January 10, 2017.
  • Ingraham, C. Drug policy experts and advocates implore DEA to keep opiate-like plant legal. The Washington Post. Dec 2, 2017. Accessed February 26, 2020.
  • American Kratom Association. The Facts About Kratom. Accessed January 10, 2017. 
  • Henningfield, J. Factors Related to the Relative Abuse Potential of Mitragyna Speciosa (Kratom) and Mitragynine in the form of VivaZen. Written Summary of Oral Testimony for the State of Wisconsin Controlled Substances Board.
    August 14, 2015. Accessed January 10, 2017.
  • Analysis Shows No Basis For DEA To Restrict Herb Kratom. American Kratom Association. December 1, 2016. Accessed January 10, 2017. 
  • PBS News Hour. Harven M. Herbal drug kratom faces uncertain legal future, despite public outpouring. December 12, 2016. Accessed January 10, 2017 at https://www.pbs.org/newshour/health/whats-next-kratom